BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 16 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 17 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 18 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 16 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 17 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 18 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
Market News

Diebold (NYSE: DBD): Q4 2019 Earnings Snapshot

— Diebold Nixdorf (NYSE: DBD) reported its fourth-quarter 2019 adjusted earnings of $0.47 per share versus $0.50 per share expected. — Total net sales declined by 11% to $1.15 billion versus $1.16 billion expected. The results were impacted by divestitures and other deliberate actions to improve the quality of revenue. — Sales from Eurasia Banking […]

$DBD February 11, 2020 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$DBD · Earnings

— Diebold Nixdorf (NYSE: DBD) reported its fourth-quarter 2019 adjusted earnings of $0.47 per share versus $0.50 per share expected. — Total net sales declined by 11% to $1.15 billion versus $1.16 billion expected. The results were impacted by divestitures and other deliberate actions to improve the quality of revenue. — Sales from Eurasia Banking […]

· February 11, 2020

— Diebold Nixdorf (NYSE: DBD) reported its fourth-quarter 2019 adjusted earnings of $0.47 per share versus $0.50 per share expected.

— Total net sales declined by 11% to $1.15 billion versus $1.16 billion expected. The results were impacted by divestitures and other deliberate actions to improve the quality of revenue.

Earnings Update by AlphaStreet

— Sales from Eurasia Banking dropped by 13% and that from the Americas Banking declined by 3%. Total retail sales fell by 18%.

— Looking ahead into the full year 2020, the company expects its total revenue in the range of $4.2-4.3 billion. The consensus estimates revenue of $4.27 billion.

— Adjusted EBITDA is expected to be in the range of $430-470 million and net cash provided by operating activities is predicted to be in the $170-200 million range for the full year.

ADVERTISEMENT

— Capital expenditures are anticipated to be about $70 million while free cash flow is projected to be $100-130 million for the full year 2020.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT